- ►nih.gov - Free from Publisher M Kitamura, N Kitaichi, M Takeuchi, H … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Background/aims: Advanced glycation end products (AGEs) are considered to act as
mediators of both age related pathologies and diabetic complications. It was
recently reported that glyceraldehyde derived AGE (AGE-2) has a strong ... Cited by 2 - Related articles - BL Direct - All 8 versions
P Yang, W Fang, L Wang, F Wen, W Wu, A … - American Journal of Ophthalmology, 2008 - Elsevier Purpose: We longitudinally investigated macular function by multifocal
electroretinography (mfERG) in a cohort of patients with Vogt-Koyanagi-Harada
(VKH) syndrome. DESIGN: Prospective study. METHODS: VKH syndrome was ... Cited by 3 - Related articles - All 21 versions
S Aisenbrey, C Lüke, HD Ayertey, S Grisanti, … - Graefe's archive for clinical and experimental …, 2003 - Springer Abstract Purpose: To report a case of Vogt–Koyanagi–Harada (VKH) syndrome
associated with cutaneous pigmented malignant melanoma (MM) and non-pigmented
nodular metastasis after a 10-year recur- rence-free interval. Methods: ... Cited by 3 - Related articles - BL Direct - All 4 versions
- ►nih.gov - Free from Publisher B Li, P Yang, H Zhou, X Huang, H Jin, L Chu, Y … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Results: The level of IFN-γ, but not IL-2 and IL-4, was significantly higher in
the supernatants of stimulated PBMC in patients than in controls. A
significantly increased T-bet mRNA was found in VKH patients during an ... Cited by 9 - Related articles - BL Direct - All 9 versions
M Khairallah, S Zaouali, R Messaoud, S … - International Ophthalmology, 2007 - Springer Abstract Objective To analyze the clinical profile of Vogt- Koyanagi-Harada
(VKH) disease in Tunisia, North Africa. Methods We retrospectively reviewed the
clinical records of 49 patients diagnosed with VKH disease at the ... Cited by 4 - Related articles - BL Direct - All 3 versions
S Sugita, H Takase, T Kawaguchi, C Taguchi, … - International Ophthalmology, 2007 - Springer Abstract Aim To determine whether T lymphocytes of patients with
Vogt–Koyanagi–Harada (VKH) dis- ease cross-react with peptides of
melanocytes and with exogenous antigens. Methods Cross-reactivity with ... Cited by 4 - Related articles - BL Direct - All 3 versions
AS Al-Kharashi, H Aldibhi, H Al-Fraykh, D … - International Ophthalmology, 2007 - Springer Abstract Purpose To identify prognostic factors for final visual outcome,
development of complications, and recurrent inflammation in patients with Vogt-
Koyanagi-Harada (VKH) disease. Methods All patients diagnosed with acute ... Cited by 4 - Related articles - BL Direct - All 3 versions
A Gupta, S Kamal, V Gupta, P Bambery, B … - Ocular Immunology and Inflammation, 2007 - informahealthcare.com Purpose: To report the HLA profile of VKH patients from India. Method: Forty-one
patients and 50 controls were studied. Phenotyping using a lymphocytotoxicity
assay was done for HLA-A and -B. DNA-based sequence-specific low resolution ... Cited by 4 - Related articles - BL Direct - All 7 versions
